Systematic identification and validation of candidate genes for detection of circulating tumor cells in peripheral blood specimens of colorectal cancer patients

International Journal of Oncology

Volumn 33, Issue 5, 2008, Pages 1001-1010

  Findeisen, Peter ^a   Röckel, Matthias ^a   Nees, Matthias ^a,c   Röder, Christian ^b   Kienle, Peter ^a   von Knebel Doeberitz, Magnus ^a   Kalthoff, Holger ^b   Neumaier, Michael ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

Circulating tumor cells; Clade B (ovalbumin); Colorectal cancer; Member 5; Real time RT PCR; Serine (or cysteine) proteinase inhibitor

Indexed keywords

DIPEPTIDASE; DIPEPTIDASE 1; HYPOCALCIN; HYPOCALCIN 1; SERINE PROTEINASE INHIBITOR CLADE B MEMBER 5; TUMOR MARKER; UNCLASSIFIED DRUG; VISININ; VISININ LIKE 1 PROTEIN; GLYCOPROTEIN; MESSENGER RNA; NEUROCALCIN; SERINE PROTEINASE INHIBITOR; SERPIN B5; SERPIN-B5; VSNL1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER PATIENT; CANCER TISSUE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MARKER GENE; MINIMAL RESIDUAL DISEASE; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TUMOR EMBOLISM; VALIDATION PROCESS; BLOOD; CASE CONTROL STUDY; CHEMISTRY; COLORECTAL TUMOR; GENETICS; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; REPRODUCIBILITY; TUMOR CELL LINE; UPREGULATION; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DIPEPTIDASES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HUMANS; MALE; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING; NEUROCALCIN; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SERPINS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; YOUNG ADULT;

EID: 58149182214     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000088     Document Type: Article

References (45)

1. Moertel C, Fleming T, MacDonald J, et al: Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322: 352-358, 1990.
2. Wichmann M, Müller C, Hornung H, et al: Results of long-term follow-up after curative resection of Dukes A colorectal cancer. World J Surg 26: 732-736, 2002.
3. Sobin L and Fleming I: TNM classification of malignant tumors, fifth edition (1997). Cancer 80: 1803-1804, 1997.
4. Liefers G, Cleton-Jansen A, van de Velde C, et al: Micrometastases and survival in stage II colorectal cancer. N Engl J Med 339: 223-228, 1998.
5. Vogel I and Kalthoff H: Disseminated tumour cells. Their detection and significance for prognosis of gastrointestinal and pancreatic carcinomas. Virchows Archiv 439: 109-117, 2001.
6. Vlems F, Wobbes T, Punt C, et al: Detection and clinical relevance of tumor cells in blood and bone marrow of patients with colorectal cancer. Anticancer Res 23: 523-530, 2003.
7. Jung R, Petersen K, Krüger W, et al: Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes. Br J Cancer 81: 870-873, 1999.
8. Jung R, Krüger W, Hosch S, et al: Specificity of reverse transcriptase polymerase chain reaction assays designed for the detection of circulating cancer cells is influenced by cytokines in vivo and in vitro. Br J Cancer 78: 1194-1198, 1998.
9. Park S, Lee B, Kim I, et al: Immunobead RT-PCR versus regular RT-PCR amplification of CEA mRNA in peripheral blood. J Cancer Res Clin Oncol 127: 489-494, 2001.
10. Zippelius A, Kufer P, Honold G, et al: Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow. J Clin Oncol 15: 2701-2708, 1997.
11. Tsavellas G, Patel H and Allen-Mersh T: Detection and clinical significance of occult tumour cells in colorectal cancer. Br J Surg 88: 1307-1320, 2001.
12. Lacroix J and Doeberitz M: Technical aspects of minimal residual disease detection in carcinoma patients. Semin Surg Oncol 20: 252-264, 2001.
13. Krüger W, Jung R, Krüger N, et al: Sensitivity of assays designed for the detection of disseminated epithelial tumor cells is influenced by cell separation methods. Clin Chem 46: 435-436, 2000.
14. Vlems F, Diepstra J, Cornelissen I, et al: Limitations of cytokeratin 20 RT-PCR to detect disseminated tumour cells in blood and bone marrow of patients with colorectal cancer: expression in controls and downregulation in tumour tissue. Mol Pathol 55: 156-163, 2002.
15. Champelovier P, Mongelard F and Seigneurin D: CK20 gene expression: technical limits for the detection of circulating tumor cells. Anticancer Res 19: 2073-2078, 1999.
16. Klein C, Blankenstein T, Schmidt-Kittler O, et al: Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer. Lancet 360: 683-689, 2002.
17. Mitas M, Mikhitarian K, Walters C, et al: Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel. Int J Cancer 93: 162-171, 2001.
18. Bosma A, Weigelt B, Lambrechts A, et al: Detection of circulating breast tumor cells by differential expression of marker genes. Clin Cancer Res 8: 1871-1877, 2002.
19. Alon U, Barkai N, Notterman D, et al: Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc Natl Acad Sci USA 96: 6745-6750, 1999.
20. Kitahara O, Furukawa Y, Tanaka T, et al: Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia. Cancer Res 61: 3544-3549, 2001.
21. Notterman D, Alon U, Sierk A, et al: Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res 61: 3124-3130, 2001.
22. Williams N, Gaynor R, Scoggin S, et al: Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference. Clin Cancer Res 9: 931-946, 2003.
23. Zou T-T, Selaru F, Xu Y, et al: Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon. Oncogene 21: 4855-4862, 2002.
24. Su A, Welsh J, Sapinoso L, et al: Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res 61: 7388-7393, 2001.
25. Ross D, Scherf U, Eisen M, et al: Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 24: 227-235, 2000.
26. Rhodes D, Yu J, Shanker K, et al: ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6: 1-6, 2004.
27. Warrington J, Nair A, Mahadevappa M, et al: Comparison of human adult and fetal expression and identification of 535 housekeeping/ maintenance genes. Physiol Genom 2: 143-147, 2000.
28. Rozen S and Skaletsky H: Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132: 365-386, 2000.
29. Livak K and Schmittgen T: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408, 2001.
30. Ghossein R, Bhattacharya S and Rosai J: Molecular detection of micrometastases and circulating tumor cells in solid tumors. Clin Cancer Res 5: 1950-1960, 1999.
31. Jung R, Ahmad-Nejad P, Wimmer M, et al: Quality management and influential factors for the detection of single metastatic cancer cells by reverse transcriptase polymerase chain reaction. Eur J Clin Chem Clin Biochem 35: 3-10, 1997.
32. Eisen MB, Spellman PT, Brown PO, et al: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95: 14863-14868, 1998.
33. Wharton R, Jonas S, Glover C, et al: Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription-PCR assays and multiple blood samples. Clin Cancer Res 5: 4158-4163, 1999.
34. Yin J, Shackel N, Zekry A, et al: Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green I. Immunol Cell Biol 79: 213-221, 2001.
35. Baker M, Mikhitarian K, Osta W, et al: Molecular detection of breast cancer cells in the peripheral blood of advanced-stage breast cancer patients using multimarker real-time reverse transcription-polymerase chain reaction and a novel porous barrier density gradient centrifugation technology. Clin Cancer Res 9: 4865-4871, 2003.
36. Burchill S, Lewis I and Selby P: Improved methods using the reverse transcriptase polymerase chain reaction to detect tumour cells. Br J Cancer 79: 971-977, 1999.
37. Vlems F, Diepstra J, Cornelissen I, et al: Investigations for a multi-marker RT-PCR to improve sensitivity of disseminated tumor cell detection. Anticancer Res 23: 179-186, 2003.
38. McIver C, Lloyd J, Hewett P, et al: Dipeptidase 1: a candidate tumor-specific molecular marker in colorectal carcinoma. Cancer Lett 209: 67-74, 2004.
39. Wentzensen N, Wilz B, Findeisen P, et al: Identification of differentially expressed genes in colorectal adenoma compared to normal tissue by suppression subtractive hybridization. Int J Oncol 24: 987-994, 2004.
40. Luppi M, Morselli M, Bandieri E, et al: Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene. Annal Oncol 7: 619-624, 1996.
41. Umekita Y, Souda M and Yoshida H: Expression of maspin in colorectal cancer. In Vivo 20: 797-800, 2006.
42. Bettstetter M, Woenckhaus M, Wild P, et al: Elevated nuclear maspin expression is associated with microsatellite instability and high tumour grade in colorectal cancer. J Pathol 205: 606-614, 2005.
43. Zheng H, Tsuneyama K, Cheng C, et al: Maspin expression was involved in colorectal adenoma-adenocarcinoma sequence and liver metastasis of tumors. Anticancer Res 27: 259-265, 2007.
44. Sheng S, Carey J, Seftor E, et al: Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc Natl Acad Sci USA 93: 11669-11674, 1996.
45. Ballestrero A, Garuti A, Bertolotto M, et al: Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes: possible relevance to the assays for the detection of micrometastatic breast cancer. Br J Cancer 92: 1948-1952, 2005.